Literature DB >> 12560781

Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution.

Christian Passler1, Gerhard Prager, Christian Scheuba, Klaus Kaserer, Georg Zettinig, Bruno Niederle.   

Abstract

OBJECTIVE: To evaluate and compare staging systems for differentiated thyroid carcinoma and predicted outcome in an endemic goiter region with iodine substitution and to examine the risk profile of differentiated thyroid carcinoma and compare it against nongoiter regions. SUMMARY BACKGROUND DATA: Differentiated (papillary or follicular) thyroid carcinoma has a favorable prognostic outcome. In numerous studies prognostic factors have been identified and staging systems created, particularly in Anglo-American centers (nonendemic goiter regions), to evaluate individual prognostic outcome.
METHODS: In a retrospective study, the authors assessed 440 patients with differentiated thyroid carcinoma (papillary, n = 293; follicular, n = 147) and a long-term follow-up of median 10.6 years to determine the predictive accuracy of nine staging systems applicable to the study population; the systems were compared by calculating the proportion of variation explained.
RESULTS: With regard to cause-specific mortality, the difference between the respective stages and/or risk groups was highly significant for every staging system. By means of calculating the proportion of variation explained, MACIS scoring supplied the most reliable prognostic information for differentiated thyroid carcinoma (relative importance 16.93%). EORTC and UICC/AJCC systems had a relative importance of 16.34% and 13.96%, respectively, also a high level of accuracy; this implies that they are superior to the other six staging systems. If we separate papillary and follicular carcinoma, for the former the MACIS score with a relative importance of 15.05% is clearly superior to the other staging systems, whereas for the latter the EORTC score and the UICC/AJCC staging system, with relative importance of 17.04% and 16.58%, respectively, yield the best prognostic information.
CONCLUSIONS: By applying staging systems in an endemic goiter region with iodine substitution, the best prognostic information for papillary thyroid carcinoma has been achieved with the MACIS score, while for follicular thyroid carcinoma the EORTC score and the UICC/AJCC system have the best prognostic accuracy. Because of the individual factors, which are easy to obtain and generally available (age, T, N, M classification), the uncomplicated handling, and the widespread use and the good predictive accuracy, the UICC/AJCC classification is the staging system of choice for comparing published results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12560781      PMCID: PMC1522138          DOI: 10.1097/01.SLA.0000048449.69472.81

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  31 in total

1.  A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group.

Authors:  D P Byar; S B Green; P Dor; E D Williams; J Colon; H A van Gilse; M Mayer; R J Sylvester; M van Glabbeke
Journal:  Eur J Cancer       Date:  1979-08       Impact factor: 9.162

2.  An expanded view of risk-group definition in differentiated thyroid carcinoma.

Authors:  B Cady; R Rossi
Journal:  Surgery       Date:  1988-12       Impact factor: 3.982

3.  Natural history, treatment, and course of papillary thyroid carcinoma.

Authors:  L J DeGroot; E L Kaplan; M McCormick; F H Straus
Journal:  J Clin Endocrinol Metab       Date:  1990-08       Impact factor: 5.958

4.  Does the method of management of papillary thyroid carcinoma make a difference in outcome?

Authors:  L J DeGroot; E L Kaplan; F H Straus; M S Shukla
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

5.  Prognostic importance of histologic grading in papillary thyroid carcinoma.

Authors:  L A Akslen
Journal:  Cancer       Date:  1993-11-01       Impact factor: 6.860

6.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; S M Jhiang
Journal:  Am J Med       Date:  1994-11       Impact factor: 4.965

7.  [Iodine supply and struma in Austria].

Authors:  G Galvan
Journal:  Acta Med Austriaca       Date:  1993

8.  Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.

Authors:  I D Hay; E J Bergstralh; J R Goellner; J R Ebersold; C S Grant
Journal:  Surgery       Date:  1993-12       Impact factor: 3.982

9.  Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid cancer.

Authors:  J L Pasieka; J Zedenius; G Auer; L Grimelius; A Höög; G Lundell; G Wallin; M Bäckdahl
Journal:  Surgery       Date:  1992-12       Impact factor: 3.982

10.  Multifactorial analysis of survival in thyroid cancer. Pitfalls of applying the results of published studies to another population.

Authors:  P Hannequin; J C Liehn; M J Delisle
Journal:  Cancer       Date:  1986-10-15       Impact factor: 6.860

View more
  14 in total

1.  Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer.

Authors:  Daniel Mankarios; Peter Baade; Pip Youl; Robin H Mortimer; Adedayo A Onitilo; Anthony Russell; Suhail A R Doi
Journal:  Endocrine       Date:  2013-10-31       Impact factor: 3.633

2.  Comparison of prognostic scoring systems in follicular thyroid cancer.

Authors:  K W Teo; N K Yuan; W B Tan; R Parameswaran
Journal:  Ann R Coll Surg Engl       Date:  2017-07       Impact factor: 1.891

3.  A review of the management and prognosis of thyroid carcinoma with tracheal invasion.

Authors:  Anquan Peng; Youzhong Li; Xinming Yang; Zian Xiao; Qingla Tang; Qin Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-28       Impact factor: 2.503

4.  Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.

Authors:  Chung-Yau Lo; Wai-Fan Chan; King-Yin Lam; Koon-Yat Wan
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

Review 5.  Staging systems for papillary thyroid carcinoma: a review and comparison.

Authors:  Brian Hung-Hin Lang; Chung-Yau Lo; Wai-Fan Chan; King-Yin Lam; Koon-Yat Wan
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

6.  Extent of surgery affects survival for papillary thyroid cancer.

Authors:  Karl Y Bilimoria; David J Bentrem; Clifford Y Ko; Andrew K Stewart; David P Winchester; Mark S Talamonti; Cord Sturgeon
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

7.  Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.

Authors:  Ning Qu; Ling Zhang; Wei-Li Wu; Qing-Hai Ji; Zhong-Wu Lu; Yong-Xue Zhu; Dao-Zhe Lin
Journal:  Tumour Biol       Date:  2016-01-07

8.  Staging systems for papillary thyroid carcinoma: a study of 2 tertiary referral centers.

Authors:  Brian Hung-Hin Lang; Sin-Ming Chow; Chung-Yau Lo; Stephen C K Law; King-Yin Lam
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

9.  New prognostic scales LAST-1 and LAST-2: supporting prediction and staging of thyroid cancer.

Authors:  Andrzej J Lachinski; Tomasz Stefaniak; Jarek Kobiela; Saxon Connor; Zbigniew Gruca; Zbigniew Sledzinski
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

10.  Identification of Intermediate- to High-Risk Papillary Thyroid Carcinoma Patients Who May Be Safely Managed without the Performance of Delayed Stimulated Thyroglobulin Measurements following Total Thyroidectomy and Radioactive Iodine Therapy.

Authors:  Kyung-Hee Kim; Min-Hee Kim; Ye-Jee Lim; Ihn Suk Lee; Ja-Seong Bae; Dong-Jun Lim; Ki Hyun Baek; Jong Min Lee; Moo-Il Kang; Bong-Yun Cha
Journal:  Int J Endocrinol       Date:  2015-01-12       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.